Lumenis and Fotona Sign Distribution Agreement to Market QX MAX Q-Switched Laser Technology to North America

Share Article

Highest, single-pulse-energy Q-switched laser for tattoo and pigmented lesion removal.

the FDA-cleared QX MAX Nd:YAG laser is used for the treatment of pigmented lesions and most colors of tattoos

Lumenis Ltd., the world's largest medical laser company developing, manufacturing and distributing a broad range of medical lasers and sophisticated energy delivery equipment for surgical, aesthetic and ophthalmic applications, announces the signing of a distribution agreement with Fotona d.d. Lumenis will be the exclusive distributor of Fotona’s QX MAX Q-Switched laser in North America, to serve aesthetic practitioners who are interested in offering their customers treatment of pigmented and vascular lesions, and removal of colored ink tattoos.

Among a range of cleared indications for use, the FDA-cleared QX MAX Nd:YAG laser is used for the treatment of pigmented lesions and most colors of tattoos. With five lasers in one system, QX MAX has the highest single pulse energies for large spot treatment. The benefit of the laser’s various wavelengths enables aesthetics practitioners to optimize the removal of multi-colored tattoos and treat a range of pigmentation and vascular lesions, acne scars and wrinkle reduction. QX MAX has the ideal wavelength which is minimally absorbed in melanin. This allows the safe use for all skin types, including darker skin types.

“The Q-switch market potential is growing. We identified Fotona’s product as a technically superior, top of the line laser which expands our treatment offerings by enabling practitioners to offer tattoo removal and the treatment of deep pigmented lesions, among other applications,” said Tzipi Ozer-Armon, CEO of Lumenis.

“I am pleased that the largest medical laser company has decided to partner with Fotona. This agreement is a strong endorsement of our technology, and we look forward to working with Lumenis' expert team,” said Matjaz Lukac, President of Fotona.

"We are very excited to further expand our product portfolio with quality aesthetics applications,” said Bob Di Silvio, Lumenis’ President of the Americas. “It is a privilege to team up with one of the respected members of the laser industry and true professionals at Fotona to deliver QX MAX to the US market."

For more information on the QX MAX Q-Switched laser, contact Lumenis, Inc. at (877) 586-3647 or visit

About Lumenis

Lumenis, the world's largest medical laser company, is a global developer, manufacturer and distributor of laser and light-based devices for surgical, aesthetic and ophthalmic applications, with more than 900 employees worldwide. Lumenis has 265 registered patents, over 260 FDA clearances, an installed base of over 80,000 systems and a presence in over 80 countries. Lumenis endeavors to bring the finest state of the art technology products to the market, fulfilling the highest standards of excellence, quality and reliability, delivering premium value and service to its customers. The name Lumenis is derived from the Latin words meaning ”Light of Life” highlighting the light - the basis of our technologies - used to enhance life. For more information about Lumenis and its products, please visit:

About Fotona

Fotona is one of the top manufacturers of medical laser systems, based in Europe. The company is committed to state-of-the-art, in-house production. Fotona’s in-house manufacturing and stringent testing of all components, in compliance with applicable international standards, ensures that systems are of the highest quality, reliability and durability.

For further information contact:

Julie Shafiki
Director, Global Marketing Communications
e-mail: julie.shafiki (at) lumenis (dot) com

Lumenis® and the Lumenis logo are trademarks or registered trademarks of Lumenis.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Julie Shafiki
Lumenis LTD
Email >
Visit website